NM_022817.3:c.2185G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_022817.3(PER2):​c.2185G>A​(p.Val729Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00175 in 1,614,158 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 56 hom. )

Consequence

PER2
NM_022817.3 missense

Scores

1
3
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.57

Publications

8 publications found
Variant links:
Genes affected
PER2 (HGNC:8846): (period circadian regulator 2) This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene may increase the risk of getting certain cancers and have been linked to sleep disorders. [provided by RefSeq, Jan 2014]
PER2 Gene-Disease associations (from GenCC):
  • advanced sleep phase syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • advanced sleep phase syndrome 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006024629).
BP6
Variant 2-238255792-C-T is Benign according to our data. Variant chr2-238255792-C-T is described in ClinVar as Benign. ClinVar VariationId is 770136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0037 (564/152288) while in subpopulation AMR AF = 0.0297 (454/15300). AF 95% confidence interval is 0.0274. There are 6 homozygotes in GnomAd4. There are 317 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 564 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PER2NM_022817.3 linkc.2185G>A p.Val729Ile missense_variant Exon 18 of 23 ENST00000254657.8 NP_073728.1 O15055-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PER2ENST00000254657.8 linkc.2185G>A p.Val729Ile missense_variant Exon 18 of 23 1 NM_022817.3 ENSP00000254657.3 O15055-1
PER2ENST00000707129.1 linkc.2185G>A p.Val729Ile missense_variant Exon 18 of 23 ENSP00000516757.1 O15055-1
PER2ENST00000707130.1 linkc.2185G>A p.Val729Ile missense_variant Exon 18 of 23 ENSP00000516758.1 O15055-1
ENSG00000225057ENST00000456601.1 linkn.*159C>T downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.00367
AC:
559
AN:
152170
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00138
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0294
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00713
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00695
AC:
1748
AN:
251448
AF XY:
0.00531
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.0439
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00924
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000791
Gnomad OTH exome
AF:
0.00537
GnomAD4 exome
AF:
0.00155
AC:
2266
AN:
1461870
Hom.:
56
Cov.:
31
AF XY:
0.00129
AC XY:
941
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.000418
AC:
14
AN:
33480
American (AMR)
AF:
0.0420
AC:
1880
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00587
AC:
233
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111996
Other (OTH)
AF:
0.00202
AC:
122
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
168
336
503
671
839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00370
AC:
564
AN:
152288
Hom.:
6
Cov.:
33
AF XY:
0.00426
AC XY:
317
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00137
AC:
57
AN:
41560
American (AMR)
AF:
0.0297
AC:
454
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00715
AC:
37
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68010
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00107
Hom.:
3
Bravo
AF:
0.00565
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00527
AC:
640
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.47
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0060
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
3.2
M
PhyloP100
2.6
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.83
N
REVEL
Benign
0.094
Sift
Benign
0.036
D
Sift4G
Uncertain
0.040
D
Polyphen
0.60
P
Vest4
0.14
MVP
0.18
MPC
0.19
ClinPred
0.054
T
GERP RS
0.96
Varity_R
0.031
gMVP
0.26
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4429421; hg19: chr2-239164433; API